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Summary Objectives: Disodium cromoglycate (DSCG) and nedocromil sodium are
anti-asthma drugs that have a variety of physiological and biological effects. We
examined whether DSCG affects the induction of cysteinyl leukotriene (cysLT)
synthesis during dimethyl sulfoxide (DMSO)-induced granulocytic differentiation in
HL-60 cells.
Methods: HL-60 cells were differentiated to mature granulocyte-like cells by DMSO
in the presence or absence of DSCG for 5 days. Then, we measured A23187-stimulated
production of LTC4, an initial product of cysLTs. We also examined the mRNA
expression and enzyme activity of LTC4 synthase and other LT-synthetic enzymes.
Results: The amount of LTC4 production was 732.0719.0 pg/10
6 cells in DMSO-
differentiated HL-60 cells. The value was significantly decreased to 420.7722.7 pg/
106 cells in the presence of DSCG at 100 mg/ml. The DMSO-induced mRNA expression
and enzyme activity of LTC4 synthase was also suppressed by DSCG.
Conclusions: Our results indicate that DSCG suppresses the DMSO-induced LTC4
synthase-activity by inhibiting mRNA expression of LTC4 synthase, which might be a
novel anti-allergic action of DSCG.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
Cromons, disodium cromoglycate (DSCG) and nedo-
cromil sodium, are classified as anti-allergy drugs
that are clinically effective for allergic diseases,
including bronchial asthma.1–6 DSCG inhibits med-
iator releases from a wide range of cells2,5 and
affects cell differentiation.7–9
The human leukemia (HL)-60 is a cell line that
can be used in an experimental model providing the
possibility to examine the regulation of arachidonic
acid (AA) metabolism in myeloid cells. HL-60 cells
can be differentiated into morphologically mature
granulocyte like cells,10,11 which produce a various
kind of arachidonate metabolites including leuko-
trienes. Leukotriene (LT) B4 and cysteinyl leuko-
trienes (cysLTs; LTC4, LTD4 and LTE4) are important
chemical mediators of allergic diseases including
bronchial asthma. Messenger RNA(mRNA) and
enzyme activities for LT-synthetic enzymes and
protein, such as cytosolic phospholipase A2 (cPLA2),
five-lipoxygenase (5-LO), five-lipoxygenase activat-
ing protein (FLAP), LTA4 hydrolase and LTC4 synthase,
is known to be induced during DMSO-initiated
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differentiation of HL-60 cells.12–16 We examined
whether DSCG affected the induction of LT-syn-
thetic activities in the process of DMSO-initiated
cell differentiation.
Materials and methods
Materials
HL-60 cells were obtained from the Japanese
Cancer Research Resources Bank (Tokyo, Japan).
Oligo (dT) primer, RNA guard, ethidium bromide
and a 100 bp DNA ladder were obtained from
Pharmacia (Uppsala, Sweden), RPMI 1640, antibio-
tic-antimyotic liquid (penicillin G, streptomycin,
amphotericine B), fetal bovine serum, Moloney
murine leukemia virus reverse transcriptase,
dithiothreitol and 5 reaction buffer were from
Gibco BRL (Grand Island, NY), deoxyribonucleoside
triphosphate (dNTP) mixture, recombinant Taq DNA
polymerase and 10 polymerase chain reaction
(PCR) buffer from Takara Shuzo (Kyoto, Japan), and
Isogen was from Nippon Gene Co. (Tokyo, Japan);
A23187, glutathion (reduced form) and diethyl
pyrocarbonate (DEPC) was obtained from Sigma
Chemical Co. (St. Louis, MO). Agarose MS-12 was
from Cosmo BIO (Tokyo, Japan). Hepes, Norit A, and
EDTA were obtained from Wako (Osaka, Japan).
LTB4, LTC4 and TXB2 were obtained from Funakoshi
(Tokyo, Japan). We purchased [5,6,8,9,11,12,
15,-3H]-LTB4, [14,15,19,20-
3H]-LTC4 and [5, 6, 8,
9, 11, 12, 14, 15-3H]-TXB2 from DuPont NEN
(Boston, MA). Anti-sera to LTB4, LTC4 and TXB2
were provided by Professor Daniel Tai (University of
Kentucky, Lexington, KY). PCR primer pairs specific
for beta-actin, cPLA2, 5-LO, FLAP, LTC4 synthase
and LTA4 hydrolase were from Nippon Seifun (Tokyo,
Japan). All other materials were special grade and
purchased from commercial sources.
Methods
Culture and manipulation of HL-60 cells
Cells were cultured in RPMI-1640 medium supple-
mented with an antibiotic-antimycotic solution
(penicillin G 100 unit/ml, streptomycin 100 mg/ml,
amphotericin B 0.25 mg/ml), 26mM NaHCO3 and
10% FBS at 371C under a 5% CO2 atmosphere. Near
confluent cells were seeded into polystyrene
culture dishes at a density of 5 105 cells/ml in
10ml of RPMI-1640 with 10% FBS and incubated for
5 days with or without 1.5% (v/v) DMSO in the
absence or presence of DSCG (0–100 mg/ml), keto-
tifen (0–106 M), or pranlukast (0–106 M) at 371C
under a 5% CO2 atmosphere. After incubation, the
cells were collected and washed twice with
phosphate buffered saline (PBS) before experi-
ments. Cell viability was checked using Trypan blue
stain. Differentiation of the cells was determined
by morphological changes using May-Grunwald-
Giemsa staining.
In a separate experiment, we conducted a time-
course study in order to clarify the time-dependent
action of DSCG on LT-synthetic activity. DSCG was
added into the medium on days 0, 1, 2, 3, 4 and 5 at
100 mg/ml (incubation periods with DSCG; 5, 4, 3,
2, 1 and 0 days, respectively).
Measurement of LTB4, LTC4 and TXB2 synthesis
After incubation with DMSO and DSCG as described
above, the cells (5 105 cells) were seeded into 24-
well dishes in 1ml of RPMI-1640 per well. The cells
were stimulated with A23187 (105 M) for 15min at
371C, the medium was collected and then LTB4 was
measured using a radioimmunoassay (RIA), as
previously described.17 In brief, 100 ml of medium
was incubated at 41C for 10 h with 100 ml each of
anti-LTB4 anti-serum, [
3H]-LTB4, and 50mM sodium
phosphate buffer (pH7.4) containing 0.9% NaCl and
gamma-globulin (1mg/ml). Free [3H]-LTB4 was
separated by centrifugation at 3000 rpm for
10min after adding of 0.5ml of charcoal-coated
gamma-globulin to the assay mixture. The super-
natant was transferred to scintillation vials, and
radioactivity was measured using a liquid scintilla-
tion counter (model LS 7500; Beckman, Irvine, CA).
The amount of LTB4 was calculated from a standard
curve. The detectable range of LTB4 was from 16 to
1000 pg/100 ml. RIA for LTC4 was performed under
the same conditions, except that anti-LTC4 anti-
serum and [3H]-LTC4 were used instead of anti-LTB4
anti-serum and [3H]-LTB4. The detectable range of
LTC4 was from 8 to 1000 pg/100 ml. RIA for TXB2 was
performed under the same conditions, except that
anti-TXB2 anti-serum and [
3H]-TXB2 were used instead
of anti-LTB4 anti-serum and [
3H]-LTB4. The detectable
range of TXB2 was from 16 to 1000pg/100ml.
RNA extraction and RT-PCR
Cells (5 106 cells) were lysed after adding 1ml of
Isogen, then chloroform was added and the mixture
was centrifuged. The aqueous (upper) phase was
removed to another tube. Isopropanol was added
and centrifuged. The supernatant was discarded,
the pellet was resuspended in 75% ethanol and
centrifuged. Total RNA extracted from the pellet
was dissolved in 10 ml of DEPC-treated water and
quantified by measuring the absorbance at 260 nm
with a spectrometer (model DU-600; Beckman,
Irvine, CA). Complementary DNA (cDNA) was
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synthesized from the reverse transcription mixture
(final volume, 20 ml) containing 1 mg of total RNA,
1 mg of oligo (dT) primer, 4 ml of 5 reaction buffer,
2 ml of 0.25M dithiothreitol, 4 ml of dNTP mixture
(2.5mM each), 1 ml of RNA guard (5 units), 1 ml of
Moloney murine leukemia virus reverse transcrip-
tase (200 units), and DEPC-treated water. PCR
proceeded at a total volume of 50 ml containing 1 ml
of the reverse transcription reaction products, 5 ml
of 10 PCR buffer, 4 ml of dNTP mixture (2.5mM
each), 0.25 ml of Taq DNA polymerase (5 units/ml),
100 pmol of paired primers (cPLA2, 5-LO, FLAP, LTA4
hydrolase, LTC4 synthase or beta-actin), and
37.25 ml of DEPC-treated water. The DNA was
amplified with each paired primer with 28 cycles
of denaturation at 941C for 30 s, annealing at 561C
for 30 s, and extension at 721C for 1min. The
primers were: cPLA2, 5
0-ATTCTGGATTGTGCTACC
TAC, 50-AACCAGAAACGCCCAAAACTC; 5-LO, 50-AC
CATTGAGCAGATCGTGGACACGC, 50-GCAGTCCTGCT
CTGTGTAGAATGGG; FLAP, 50-CACGAAAGCAGGACC
CAGAA, 50-CAGAGCACAGCGAGGAAAGT; LTA4 hydro-
lase, 50-CCACCATCCTTCCCTTAT, 50-AAACAATCGTC
CGCAAAT; LTC4 synthase, 5
0-TCGCCGGCATCTTCTTT
CAT, 50-AGGCTCCGGCTCTTCTTTCC; beta-actin, 50-
TCCTGTGGCATCACGAAACT, 50TAGCAGGTGGCGTTT
ACGAAG. The sizes of the PCR products were
580 bp for cPLA2, 488 bp for 5-LO, 116 bp for FLAP,
208 bp for LTA4 hydrolase, 296 bp for LTC4 synthase
and 314 bp for beta-actin. Ten ml of each product
was applied on agarose gel, separated by electro-
phoresis, visualized under UV light, photographed
using the gel documentation system, Image Master
VDS (Pharmacia Biotech Co., Tokyo, Japan), and
semi-quantified as described.17
Measurement of LTA4 hydrolase- and LTC4
synthase activities
The cells were washed twice with 10ml of HEPES
buffer (137mM NaCl, 2.6mM KCl, 0.36mM NaH2-
PO4, 10mM HEPES and 1mM EDTA at pH 7.5)
containing 1mM dithothreitol, and resuspended in
the same buffer at a concentration of 108 cells/ml.
The cells were sonicated three times on ice (model
W-225R, Heat Systems-Ultrasonics, Inc., Plainview,
NY). The activities of LTA4 hydrolase and LTC4
synthase in the lysates were measured. LTA4
methylester was saponified in 95% ethanol in 0.2 N
NaOH for 30min to produce LTA4 free acid. LTA4
free acid was diluted with 20 ml of HEPES buffer
containing 10mg/ml bovine albumin (LTA4 solution,
at pH 11.5–12.1) and used within 30min as the
substrate. A mixture of cell lysates and GSH (180 ml)
was incubated for 1min at 371C, then 20 ml of the
LTA4 solution was added, and the mixture was
incubated for a further 5min at 371C. The reaction
was stopped by adding 2ml of methanol. The
production of LTB4 and LTC4 was measured using
high performance liquid chromatography (HPLC) as
described.17 In brief, the samples were partially
purified, concentrated by passing through a Sep Pak
C18 cartridge (Waters, Milford, MA) and applied to
HPLC system (TOSO, model 8010, Tokyo, Japan)
equipped with a Novapak C18 column (Waters,
Milford, MA). The samples were eluted with
acetonitrile:methanol:water:acetic acid [31:17.68:
51.24:0.68 (v/v)] at 0.8ml/min and the absorbance
was monitored using a spectrophotometer at
280 nm. The concentration of LTs was normalized
by the protein concentration determined by the
Lowry method.
Statistical analysis
The data are shown as means7SEM. The data were
statistically analyzed by one-way analysis of var-
iance. A P-value of o0.05 was defined as statisti-
cally significant.
Results
Morphological effect of DSCG on DMSO-
induced granulocytic differentiation of
HL-60 cells
Fig. 1 shows that the ratio (%) of differentiated
cells was significantly increased by DMSO treat-
ment, when compared with that of the untreated
cells. DSCG had no effect on morphological change
in granulocytic differentiation in HL-60 cells.
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Figure 1 Effect of DSCG on morphological changes
during DMSO-induced granulocytic differentiation of HL-
60 cells. The cells were incubated with 1.5% DMSO and
various concentrations of DSCG (0, 1, 10 and 100 mg/ml)
for 5 days, and morphological changes were examined as
described in Materials and Methods. Data are presented
as means7SEM. Po0:05 vs. cells without DMSO. DMSO,
dimethyl sulfoxide; DSCG, disodium cromoglycate.
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Neither ketotifen, an oral anti-allergic drug, nor
pranlukast, a cysLT1 receptor antagonist, changed
the ratio of differentiated cells (data not shown).
Effect of DSCG on LTC4-, LTB4- and TXB2-
synthesis during DMSO-induced granulocytic
differentiation of HL-60 cells
Table 1 shows that the production of LTC4, LTB4 and
TXB2 in DMSO-differentiated cells was significantly
increased, when compared to that in untreated
cells. The production of LTC4 was significantly
suppressed by DSCG. The production of LTB4 and
TXB2 was also decreased in accordance with an
increasing DSCG dose. After HL-60 cells were
differentiated by exposure to DMSO without DSCG
for 5 days, production of LTC4, LTB4 and TXB2 was
not influenced by DSCG at 1–100 mg/ml; incubation
periods for 1–12 h (data not shown).
The production of LTC4, LTB4 and TXB2 in DMSO-
treated cells tended to be decreased by ketotifen
and pranlukast, but it was not significant (Table 1).
Effect of DSCG on mRNA expression for
cPLA2, 5-LO, FLAP, LTC4 synthase and LTA4
hydrolase during DMSO-induced granulocytic
differentiation of HL-60 cells
The expression of the mRNA for cPLA2, 5-LO, FLAP,
LTC4 synthase, LTA4 hydrolase, and beta-actin in
DMSO-induced HL-60 cells is shown in Fig. 2A. The
densitometric analysis of the PCR products is
demonstrated in Fig. 2B. The abundance of mRNA
for 5LO, LTC4 synthase and LTA4 hydrolase in DMSO-
differentiated cells was significantly increased,
when compared to that of untreated cells. The
abundance of cPLA2 mRNA was decreased, whereas
the abundance of mRNA for FLAP and beta-actin
was not changed by the treatment of DMSO. The
DMSO-induced enhancement of mRNA for LTC4
synthase was dose-dependently inhibited by DSCG.
The mRNA expression for cPLA2, 5-LO, FLAP, LTA4
hydrolase was not changed by DSCG.
Effect of DSCG on the induction of LTC4
synthase- and LTA4 hydrolase activities
during DMSO-induced granulocytic
differentiation of HL-60 cells
Fig. 3A and B shows LTC4 synthase and LTA4
hydrolase activities. Five-day incubation with DMSO
(1.5%) significantly increased both of these activ-
ities. DSCG significantly inhibited LTC4 synthase
activity, but not LTA4 hydrolase activity.
Time course study for the effect of DSCG on
LTC4 synthesis during DMSO-induced
granulocytic differentiation of HL-60 cells
As shown in Fig. 4, induction of LTC4 synthetic
activity was suppressed when DSCG was added into
the medium within 48 h after DMSO treatment.
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Table 1 Action of DSCG, ketotifen and pranlukast on A23187stimulated LTC4, LTB4, TXB2 synthesis in DMSO-
differentiated HL-60 cells.
Drug LTC4 (pg/10
6 cells) LTB4 (pg/10
6 cells) TXB2 (pg/10
6 cells)
DMSO () ND ND ND
DMSO (þ ) 732.0719.0 2463.4773.7 2313.0773.3
þDSCG (mg/ml)
1 548.0729.9n 2363.3772.6 2310.0773.3
10 473.3734.1n 2299.3747.8 2260.0738.8
100 420.7722.7n 2007.6745.1n 1926.7734.1n
þKetotifen (M)
107 693.3744.1 2443.3788.2 2333.37128.2
106 645.3754.1 2313.3776.7 2113.37122.7
105 611.0738.9nn 2110.0768.9nnn 1957.6778.2nn
þ Pranlukast (M)
107 748.0756.7 2466.07343.5 2160.07122.2
106 690.0798.0 2250.07186.2 2275.07153.2
105 623.5745.4nnnn 2055.07104.1nnn 2,046.07248.2nnn
Data are presented as means7SEM. DMSO, dimethyl sulfoxide; DSCG, disodium cromoglycate. ND, not detectable.
nPo0:05 vs. cells with DMSO and without drug. nnP¼ 0.07; nnnP¼ 0.09; nnnnP¼ 0.08.
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Discussion
This study demonstrated that DSCG inhibited DMSO-
induced LTC4 synthesis and mRNA expression for
LTC4 synthase during granulocytic differentiation of
HL-60 cells. Other investigators previously reported
that DSCG inhibited the synthesis of cysLTs.2,18–22
However, these studies did not examine the mRNA
expression of LT-synthetic enzymes such as cPLA2,
5-LO, FLAP, LTA4 hydrolase and LTC4 synthase.
Among these LT-synthetic enzymes, LTC4 synthase
is a key enzyme for cysLT synthesis, and it may be
an important target for asthma treatment. In this
study we demonstrated that DSCG suppressed LTC4
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Figure 2 Effect of DSCG on mRNA expression of LT-synthetic enzymes during DMSO-induced granulocytic
differentiation of HL-60 cells. Cells were incubated with 1.5% DMSO and various concentrations of DSCG (0, 1, 10
and 100 mg/ml) for 5 days. RT-PCR was performed as described in the Materials and Methods. (A) Electrophoresis for
cPLA2 (580 bp), 5-LO (488 bp), FLAP (116 bp), LTC4 synthase (296 bp), LTA4 hydrolase (208 bp) and beta-actin (314 bp)
Lanes indicate untreated cells; DMSO (), and DMSO plus DSCG (0, 10 and 100 mg/ml). (B) Densitometric analysis of PCR
products for cPLA2, 5-LO, FLAP, LTC4 synthase and LTA4 hydrolase, normalized to beta-actin. (1): DMSO () and DSCG
(), (2): DMSO (þ ) and DSCG (), (3): DMSO (þ ) and DSCG (1 mg/ml), (4): DMSO (þ ) and DSCG (10mg/ml), (5): DMSO
(þ ) and DSCG (100 mg/ml). Data are presented as means7SEM. Po0:05 vs. 1. #Po0:05 vs. 2. DMSO, dimethyl sulfoxide;
DSCG, disodium cromoglycate.
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synthesis, an initial product of cysLTs, by inhibiting
the induction of mRNA for LTC4 synthase during
granulocytic differentiation of HL-60 cells. These
results indicate a novel anti-allergic mechanism of
DSCG. Several weeks may be necessary before the
effects of DSCG appear in patients with asthma.
Our results may explain this time lag of the
appearance of clinical efficacy and the initiation
of the drug. Marquardt et al. reported that long-
term exposure to cromolyn inhibited LTC4 genera-
tion in mouse mast cells,22 although they did not
mention the effect of DSCG on LTC4 synthase
activity in these cells. DSCG may affect induction
of the LT-synthetic enzymes during differentiation
or maturation in other inflammatory cell types
including mast cell, although there is no definite
evidence.
In this study, a higher dose of DSCG inhibited
DMSO-induced LTB4- and TXB2-synthetic activities.
This mechanism could not be explained from our
study. DSCG did not reduce mRNA expression for
cPLA2, 5-LO, FLAP, LTA4 hydrolase or cyclooxy-
genases (data not shown). A previous study demon-
strated that DSCG stabilized the membrane2,5,19
and eliminated voltage-dependent Ca2þ cur-
rents.23 A higher dose of DSCG may affect the
regulation of Ca2þ influx and lead to the inhibition
of AA metabolism in HL-60 cells. The synthesis of
LTs and TX is initiated by transmembranous stimu-
lation via various factors that increase the Ca2þ
influx, leading to cPLA2 activation. It is possible
that the activity of cPLA2, a common pivotal
enzyme for production of cyclooxygenase- and 5-
lipoxygenase-metabolism, is inhibited due to the
suppression of Ca2þ influx by high doses of DSCG.
In conclusion, we have demonstrated that DSCG
suppressed cysLT synthesis during DMSO-induced
granulocytic differentiation in HL-60 cells. These
actions may be clinically relevant to the effect of
DSCG, although the inhibition by DSCG is modest
our data might not correctly reflect the inhibitory
effect of DSCG on cysLT synthesis in vivo.
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Figure 3 Effect of DSCG on LTC4 synthase-(A) and LTA4 hydrolase-(B) activities during DMSO-induced granulocytic
differentiation of HL-60 cells. Cells were incubated with 1.5% DMSO and various concentrations of DSCG (0, 1, 10 and
100 mg/ml) for 5 days, then cell lysates were incubated with LTA4 free acid. The LTC4 and LTB4 production was measured
by HPLC as described in the Materials and methods. Data are presented as means7SEM. Po0:05 vs. cells without DMSO.
#Po0:05 vs. cells with DMSO and without DSCG. DMSO, dimethyl sulfoxide; DSCG, disodium cromoglycate.
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Figure 4 Time course study of DSCG on LTC4 synthesis
during DMSO-induced granulocytic differentiation of HL-
60 cells. Cells were incubated with DMSO for 5 days.
DSCG (100 mg/ml) was added into the medium and
incubated for various periods of time (0–5 days) before
A23187 challenge. A23187stimulated LTC4 production was
measured by RIA as described in the Materials and
methods. Data represent means7SEM. Po0:05 vs. cells
with DMSO and without DSCG. DMSO, dimethyl sulfoxide;
DSCG, disodium cromoglycate.
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